Evidence map›Paper›PMID 41982061›Full record

ArticleTransfusion2026

The status of cell and gene therapy education in medical schools-An international survey.

Edina A Wappler-Guzzetta, Alexandra M Tabacu, Elena Nedelcu

Abstract read
In one paragraph

Article in Transfusion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Edina A Wappler-GuzzettaBoston Medical Center and Boston University School of Medicine, Boston, Massachusetts, USA.
Alexandra M TabacuUniversity of California, Los Angeles, Los Angeles, California, USA.
Elena NedelcuUniversity of California, San Francisco, San Francisco, California, USA.

Funding

University of California San Francisco, Department of Laboratory Medicine
6 · The paper itself

Abstract

introductionCell and gene therapy (CGT) has emerged as a distinct medical field with more than 50 "Food and Drug Administration (FDA)"-approved products treating conditions from leukemia to sickle cell disease. Despite this therapeutic revolution and the field's inherent complexity, the status of CGT education in medical schools remains unknown. STUDY DESIGNS AND

methodsThis study explores the current state of CGT education in medical school curricula internationally and evaluates educators' perspectives on training adequacy and curriculum development needs. An international survey of 504 medical schools across six continents was conducted between September 2023 and April 2024. The 20-question poll assessed institutional characteristics, CGT educational requirements and structure, faculty resources, curriculum content, and educator perspectives. Descriptive statistics were calculated for all responses.

resultsForty-six medical schools from 21 countries responded (9.1% response rate). Only 41% (19/46) offered CGT education, predominantly as optional courses (53%) during third and fourth years. Most programs relied on 2-4 faculty with competing responsibilities; only two institutions had dedicated CGT educators. Three schools reported standardized curricula, and none formally assessed student learning. Most educators (56%) considered current CGT education inadequate, and 78% advocated expansion. Nearly two-thirds (64%) agreed to integrate professionally developed online CGT courses.

conclusionMedical education lags substantially behind the clinical adoption of CGT. The gap threatens future physicians' ability to offer optimal care. Strong educator consensus on inadequacy and interest in standardized resources signals an opportunity for intervention through collaborative curriculum initiatives.

Indexed as

Education, MedicalGenetic TherapySchools, MedicalCurriculumHumansSurveys and Questionnairescell and gene therapyeducational gapglobal surveymedical education

Identifiers

PMID41982061
PMCPMC13250344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.